Orally Active Benzoxazole Derivative as 5-HT3 Receptor Partial Agonist for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

Satoshi Yoshida,* Sojiro Shiokawa, Ken-ichi Kawano, Tomoko Ito, Hiroshi Murakami, Hisashi Suzuki, and Yasuo Sato
Pharmaceutical Research Department Meiji Seika Kaisha, Ltd., 760 Morooka-Cho, Kohoku-ku, Yokohama 222-8567 Japan
J. Med. Chem., 2005, 48 (22), pp 7075–7079
DOI: 10.1021/jm050209t
Publication Date (Web): October 12, 2005
Copyright © 2005 American Chemical Society
*

 To whom correspondence should be addressed. Tel:  +81-45-545-3133. Fax:  +81-45-541-0667. E-mail:  satoshi_yoshida@meiji.co.jp.

Abstract

Abstract Image

During our search for therapeutic agents to treat diarrhea-predominant IBS, we found that 2-substituted benzoxazole derivatives have a characteristic 5-HT3 receptor partial agonist activity with high affinity. Some of these compounds showed high in vitro metabolical stability, and 6g showed marked antidiarrhetic activity with little side effect of constipation in in vivo tests. Our results indicate that 5-HT3 receptor partial agonists might be superior as therapeutic agents to the drugs currently used for IBS treatment.

Tools

History

  • Published In Issue November 03, 2005
  • Received March 8, 2005

Recommend & Share

Related Content

Other ACS content by these authors: